FDA Accepts BLA761147 for PEGFILGRASTIM-PCCG by Accord Biopharma
The FDA has accepted the Biologics License Application for BLA761147, PEGFILGRASTIM product from Accord Biopharma.
Company
Pharmaceutical intelligence for Accord Biopharma with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.